TF and autoimmune polyendocrinopathy: When using 1.0 pM TF, no significant differences were observed comparing APS patients treated with VKA compared to a VKA-treated control group, although LT and PH were significantly higher in APS patients without VKA treatment compared to healthy controls (45).